Kratom Science & Policy: Attend the Crucial Congressional Briefing + Evening Reception

The future of kratom policy hangs in the balance. On Wednesday, December 13th, 2023, a pivotal Congressional Briefing on Kratom Science & Federal Policy will gather renowned researchers, policymakers, and passionate advocates for a critical dialogue. This event marks a significant turning point in shaping the future of kratom access and regulation.

This is your chance to make a difference. Register now for the Kratom Science & Policy Congressional Briefing and Evening Reception.

Kratom Science Policy Congressional Briefing

Kratom Lords  >  Kratom University  >  American Kratom Association  >  Kratom Science Policy Congressional Briefing

Join the Kratom Lords Family

Sign up to get 10% off on your first order. Stay updated on the latest deals, flash sales, latest Kratom news and more!

Calling All Kratom Advocates

Kratom advocates are cordially invited to attend a pivotal Congressional Briefing on Kratom Science and Policy, scheduled for Wednesday, December 13, 2023. This crucial event will take place from 11:30 AM to 1:00 PM in Room 210/12 of the Capitol Visitors Center. A complimentary lunch will be provided for all attendees.

Delving into the Science of Kratom with Esteemed Researchers

The briefing will feature insightful presentations from renowned kratom researchers, including:

  • Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA)
  • Dr. Jack Henningfield, Pinney Associates and former scientist at NIDA
  • Dr. Kirsten Smith, Johns Hopkins School of Medicine and former NIDA scientist
  • Dr. Marilyn Huestis, Senior Fellow at the Institute on Emerging Health Professions, Thomas Jefferson University and former NIDA scientist

These distinguished experts will share their invaluable knowledge and perspectives on the latest scientific advancements in kratom research. Their presentations will explore the multifaceted aspects of kratom, encompassing its potential therapeutic benefits, safety profile, and current understanding of its mechanisms of action.

Engaging in Interactive Q&A: Unraveling the Impact of Pending Legislation

In addition to these captivating presentations, the briefing will feature a dedicated Q&A session, providing an opportunity for attendees to engage directly with the speakers and gain deeper insights into the science of kratom. This interactive segment will address critical questions regarding the potential impact of pending legislation, S. 3039 and H.R. 5905, Federal Kratom Consumers Protection Act.

Fostering Connections and Advancing Advocacy: An Exclusive Evening Reception

Following the enlightening briefing, kratom advocates are invited to an exclusive Evening Reception, fostering connections and advancing advocacy efforts. This networking event will take place from 6:00 PM to 8:00 PM in Room 385 of the Russell Senate Office Building.

The reception will provide an invaluable platform for kratom advocates to connect with one another, share experiences, and strategize collective action. It will also offer an opportunity to engage with members of Congress and their staff, fostering open dialogue and raising awareness about the importance of kratom policy reform.

Ensuring a Seamless Experience: Mandatory Pre-registration:

To ensure a seamless and organized experience for all attendees, pre-registration is mandatory for both the briefing and the reception. Please click on the following Botton to access to complete the registration process promptly.

Adhering to Security Protocols: Valid Photo ID Required

All attendees are kindly requested to bring a valid photo ID to gain access to the briefing and reception venues. This measure is in compliance with standard US Senate security protocols.

Your Participation is Essential: Join Us for a Pivotal Moment in Kratom Advocacy

We extend a warm invitation to all kratom advocates to join us for this pivotal Congressional Briefing and Evening Reception. Your participation is essential in shaping the future of kratom policy and ensuring that the voices of kratom consumers are heard.

Together, we can harness the power of science-based advocacy to promote informed decision-making and advocate for responsible kratom policy.


Best Sellers


The above article is a repost. Please refer to the source provided to go to the original article., it’s holding company, and it’s owners do not endorse any published content provided herein. strongly recommends following FDA guidelines regarding Kratom. Please refer to the following link for further information.

Leave a Comment


No comments yet. Why don’t you start the discussion?

    Leave a Reply

    Your email address will not be published. Required fields are marked *